MetaCap

IRulya Therapeutics Quarterly Cash Flow Statement

NASDAQ: IRLAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

39.88-0.06 (-0.15%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

IRulya Therapeutics free cash flow

In the quarter ended Sep 30, 2026, IRulya Therapeutics generated -$9.8 million of operating cash flow and spent $71,000 on capital expenditures. That left free cash flow of -$9.9 million.

Summary generated from market data by MetaCap's automated system. Methodology

IRulya Therapeutics cash flow statement (quarterly)

IRulya Therapeutics quarterly cash flow statement
Quarter (USD)Q3 20262026-09-30Q2 20262026-06-30Q1 20262026-03-31Q4 20252025-12-31Q3 20252025-09-30Q2 20252025-06-30Q1 20252025-03-31Q4 20242024-12-31Q3 20242024-09-30Q2 20242024-06-30Q1 20242024-03-31Q4 20232023-12-31
Net Income-27.74M-75.49M35.91M-39.46M-13.44M-16.05M-15.03M-12.46M-5.49M-27.73M-11.15M-8.89M
Net Income growth (YoY)————————————
Depreciation & Amortization15.00K41.00K36.00K39.00K36.00K35.00K32.00K16.00K86.00K44.00K40.00K304.00K
Stock-Based Compensation1.64M12.09M1.29M1.19M1.25M1.27M1.39M1.13M1.12M1.22M1.27M1.09M
Change in Working Capital3.23M-66.00K2.97M2.38M1.23M-1.82M965.00K1.67M-808.00K-1.26M-381.00K1.85M
Operating Cash Flow-9.84M-18.89M-7.63M-10.48M-9.93M-11.41M-9.60M-7.55M-7.26M-8.74M-8.35M-6.08M
Capital Expenditures-71.00K00-4.00K-74.00K-126.00K-148.00K-133.00K-46.00K-39.00K-39.00K-24.00K
Investing Cash Flow-67.79M8.00M12.00M8.07M-1.78M6.04M10.90M10.87M7.11M-4.98M8.91M5.39M
Financing Cash Flow-10.00K108.93M9.44M2.03M1.38M14.41M87.00K0-5.00M35.00K190.00K57.00K
Net Change in Cash-76.16M97.82M12.35M-643.00K-10.37M9.05M1.56M3.54M-5.21M-13.92M1.06M-880.00K
Free Cash Flow-9.91M-18.89M-7.63M-10.48M-10.00M-11.54M-9.75M-7.68M-7.31M-8.78M-8.39M-6.10M

This table shows 12 quarterly periods of IRulya Therapeutics's cash flow statement, from Q3 2026 back to Q4 2023, across 10 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow IRLA's reporting calendar. What is a cash flow statement?

More financial data